Author

CharlesE Myers

Observed names: C E Myers, C. E. MYERS, C. E. Myers, CharlesE. Myers

Institutions: National Institutes of Health, National Cancer Institute

Observed institutions: National Institutes of Health, United States Department of Veterans Affairs, Mount Sinai Medical Center, National Institute of Allergy and Infectious Diseases, National Cancer Institute

OpenAlex ID: A5111967084

Administration of 3'-azido-3'-deoxythymidine, an Inhibitor of Htlv-iii/lav Replication, to Patients With Aids or Aids-related Complex

1986 · Robert Yarchoan, KentJ. Weinhold, et al. · The Lancet · 802

Effects of Suramin on Htlv-iii/lav Infection Presenting as Kaposi's Sarcoma or Aids-related Complex: Clinical Pharmacology and Suppression of Virus Replication in Vivo

1985 · Samuel Broder, JerryM Collins, et al. · The Lancet · 209

Suramin in Adrenal Cancer: Modulation of Steroid Hormone Production, Cytotoxicityin Vitro, and Clinical Antitumor Effect*

1990 · R. V. LA ROCCA, C. A. STEIN, et al. · The Journal of Clinical Endocrinology & Metabolism · 86

Regulation of the cytidine phospholipid pathways in human cancer cells and effects of 1-beta-D-arabinofuranosylcytosine: a noninvasive 31P nuclear magnetic resonance study.

1990 · P F Daly, G Zugmaier, et al. · PubMed · 53

Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular carcinoma and other solid tumors

1982 · WilliamJ. Tester, RossC. Donehower, et al. · Cancer Chemotherapy and Pharmacology · 12

Studies of the Endocrine and Paracrine Effect of Tumor Produced Factors in Human Genitourinary Cancers

1991 · W. Marston Linehan, McClellan T. Walther, et al. · Springer eBooks

Works count: 6

Citation count: 1,162

H-index: 5

I10-index: 5